Ethofumesate

CAS No. 26225-79-6

Ethofumesate( —— )

Catalog No. M28286 CAS No. 26225-79-6

Ethofumesate, a chiral herbicide, acts by inhibiting mitosis and reducing photosynthesis and plant respiration .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 Get Quote
100MG 58 Get Quote
500MG 138 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ethofumesate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethofumesate, a chiral herbicide, acts by inhibiting mitosis and reducing photosynthesis and plant respiration .
  • Description
    Ethofumesate, a chiral herbicide, acts by inhibiting mitosis and reducing photosynthesis and plant respiration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    c-Fms
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    26225-79-6
  • Formula Weight
    286.34
  • Molecular Formula
    C13H18O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC1Oc2ccc(OS(C)(=O)=O)cc2C1(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patch RJ, et al. Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6070-4.
molnova catalog
related products
  • Anigorufone

    Anigorufone (2-hydroxy-9-phenyl-1H-phenalen-1-one) is a phenylphenylcinnamone compound isolated from the seeds of Ensete superbum (Roxb.) Cheesman. and Schiekia timida.

  • Homo-VK-II-36

    Homo-VK-II-36 is a carvedilol analogue that acts by inhibiting store-?overload-induced calcium release through the RyR2 channel.

  • Astegolimab

    Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.